Stocks of Cardiff Oncology Inc (NASDAQ:CRDF) traded higher last session on Wall Street, up 4.24% to $3.44.
CRDF stock price is now -24.87% away from the 50-day moving average and 45.01% away from the 200-day moving average. The market capitalization of the company currently stands at $153.84M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On December 08, 2021, Robert W. Baird recently initiated its ‘Outperform’ rating on the stock quoting a target price of $19, while ‘Maxim Group’ rates the stock as ‘Buy’
In other news, PACE GARY W, Director bought 30,000 shares of the company’s stock on Dec 19 ’23. The stock was bought for $41,100 at an average price of $1.37. Upon completion of the transaction, the Director now directly owns 697,761 shares in the company, valued at $2.4 million. A total of 8.10% of the company’s stock is owned by insiders.
During the past 12 months, Cardiff Oncology Inc has had a low of $0.94 and a high of $6.42. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 5.91, and a quick ratio of 5.91. The fifty day moving average price for CRDF is $4.5398 and a two-hundred day moving average price translates $2.38 for the stock.
The latest earnings results from Cardiff Oncology Inc (NASDAQ: CRDF) was released for 2024-03-31. The net profit margin was -6598.85% and return on equity was -51.12% for CRDF. The company reported revenue of $0.2 million for the quarter, compared to $83000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 146.99 percent.
